Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 3
2017 3
2018 7
2019 6
2020 11
2021 21
2022 15
2023 12
2024 4
2025 18
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Radiation Exposure in Computed Tomography.
Bos D, Guberina N, Zensen S, Opitz M, Forsting M, Wetter A. Bos D, et al. Among authors: guberina n. Dtsch Arztebl Int. 2023 Mar 13;120(9):135-141. doi: 10.3238/arztebl.m2022.0395. Dtsch Arztebl Int. 2023. PMID: 36633449 Free PMC article. Review.
Temporal Muscle Thickness as a Prognostic Marker in a Real-Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma: A Multicentric Imaging Analysis.
Lazaridis L, Moenninghoff C, Bumes E, Spille DC, Müther M, Schulz T, Heider S, Agkatsev S, Schmidt T, Blau T, Oster C, Stummer W, Kessler AF, Seidel C, Grauer O, Hau P, Ahmadipour Y, Sure U, Keyvani K, Herrlinger U, Kleinschnitz C, Stuschke M, Guberina N, Herrmann K, Deuschl C, Scheffler B, Kebir S, Glas M. Lazaridis L, et al. Among authors: guberina n. Cancer Med. 2025 Apr;14(8):e70689. doi: 10.1002/cam4.70689. Cancer Med. 2025. PMID: 40260649 Free PMC article.
Long-term outcome after treatment of large uveal melanoma.
Jabbarli L, Lever M, Kiefer T, Biewald E, Rating P, Guberina M, Flühs D, Guberina N, Jabbarli R, Stuschke M, Bechrakis NE, Tsimpaki T, Fiorentzis M. Jabbarli L, et al. Among authors: guberina n. Int Ophthalmol. 2025 Jul 8;45(1):279. doi: 10.1007/s10792-025-03624-0. Int Ophthalmol. 2025. PMID: 40627056 Free PMC article.
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68Ga-FAPI-46 PET Data, and Survival Data.
Oster C, Kessler L, Blau T, Keyvani K, Pabst KM, Fendler WP, Fragoso Costa P, Lazaridis L, Schmidt T, Feldheim J, Pierscianek D, Schildhaus HU, Sure U, Ahmadipour Y, Kleinschnitz C, Guberina N, Stuschke M, Deuschl C, Scheffler B, Herrmann K, Kebir S, Glas M. Oster C, et al. Among authors: guberina n. J Nucl Med. 2024 Aug 1;65(8):1217-1223. doi: 10.2967/jnumed.123.267151. J Nucl Med. 2024. PMID: 38960714 Free article.
Response to: Commentary on Maja Guberina et al.'s study of dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma.
Guberina M, Rating P, Sokolenko E, Jabbarli L, Kiefer T, Biewald E, Guberina N, Fiorentzis M, Bechrakis N, Flühs D, Stuschke M. Guberina M, et al. Among authors: guberina n. Radiother Oncol. 2025 Aug;209:110989. doi: 10.1016/j.radonc.2025.110989. Epub 2025 Jun 13. Radiother Oncol. 2025. PMID: 40517843 No abstract available.
Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM).
Kalkavan H, Scheulen ME, Kämpgen E, Keilholz U, Heinzerling L, Lueong SS, Hlinka A, Gromke T, Ochsenreither S, Hilger RA, Grubert M, Wetter A, Guberina N, Zeschnigk M, Ferency P, Held S, Hinke A, Schuler G, Al-Ghazzawi K, Bornfeld N, Bechrakis NE, Schuler M, Bauer S, Richly H, Siveke JT. Kalkavan H, et al. Among authors: guberina n. iScience. 2025 Nov 14;28(12):114045. doi: 10.1016/j.isci.2025.114045. eCollection 2025 Dec 19. iScience. 2025. PMID: 41362626 Free PMC article.
Dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma.
Guberina M, Stuschke M, Flühs D, Jabbarli L, Kiefer T, Biewald E, Rating P, Manke H, Dalbah S, Hoffmann C, Guberina N, Pöttgen C, Fiorentzis M, Foerster A, Grunewald T, Bornfeld N, Sauerwein W, Bechrakis N, Sokolenko E. Guberina M, et al. Among authors: guberina n. Radiother Oncol. 2025 Apr;205:110775. doi: 10.1016/j.radonc.2025.110775. Epub 2025 Feb 6. Radiother Oncol. 2025. PMID: 39922315 Free article.
Decoding glioblastoma survival: unraveling the prognostic potential of olfactory function in a prospective observational study.
Oster C, Matyar A, Schmidt T, Hummel T, Hattingen E, Jokisch M, Jokisch D, Grieger J, Cappello G, Kizina K, Lazaridis L, Ahmadipour Y, Rauschenbach L, Stuschke M, Pöttgen C, Guberina N, Tertel T, Giebel B, Dreizner GL, Barbato F, Skoda EM, Scheffler B, Müther M, Herrmann K, Kleinschnitz C, Sure U, Deuschl C, Glas M, Kebir S. Oster C, et al. Among authors: guberina n. Neurol Res Pract. 2025 Jul 24;7(1):51. doi: 10.1186/s42466-025-00410-2. Neurol Res Pract. 2025. PMID: 40708059 Free PMC article.
91 results